Form 4: Vor Biopharma Director Sells Over 41K Shares

A director and 10% owner of Vor Biopharma Inc., Reprogrammed Interchange LLC, sold 41,352 shares of common stock across multiple transactions in early October 2025.

Summary

• Reprogrammed Interchange LLC, a 10% owner and director of Vor Biopharma Inc., disposed of 41,352 shares of common stock.
• The sales occurred between October 1, 2025, and October 3, 2025.
• Transaction prices ranged from $37.2057 to $42.319 per share, reflecting weighted average sale prices.
• Following these transactions, Reprogrammed Interchange LLC's beneficial ownership decreased from 1,637,660 shares to 1,597,308 shares.
• The number of shares beneficially owned reflects a 1-for-20 reverse stock split effected on September 18, 2025.
• Reid Hoffman, also a director and 10% owner, is deemed a beneficial owner through his shared control over Reprogrammed Interchange LLC but disclaims ownership beyond his pecuniary interest.

Sentiment

Score: 3

Explanation: The sentiment is negative due to significant insider selling by a director and 10% owner. While the reasons for selling are not disclosed, such transactions are often interpreted by the market as a bearish signal, potentially indicating a belief that the stock is fully valued or that future prospects are less favorable.

Negatives

• Significant selling of common stock by a director and 10% owner, Reprogrammed Interchange LLC.
• The sales occurred over several days, indicating a sustained reduction in holdings.
• Insider selling can be interpreted by the market as a lack of confidence in the company's near-term prospects.

Risks

• Potential negative market perception due to insider selling.
• Reduced alignment of interests between the reporting person and other shareholders.

Future Outlook

NA

Management Comments

• Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Industry Context

Insider selling, especially by significant shareholders and directors, is closely watched by the market as it can signal a lack of confidence or a need for liquidity by the insider. This is a common occurrence in public markets, but the scale and timing are often scrutinized.

Related Party Transactions

• Reprogrammed Interchange LLC, a 10% owner and director, engaged in sales of Vor Biopharma Inc. common stock.
• Reid Hoffman, also a director and 10% owner, is associated with Reprogrammed Interchange LLC.

Stakeholder Impact

• Shareholders: May interpret the insider selling as a negative signal, potentially leading to downward pressure on the stock price. It could erode investor confidence.

Key Dates

Recommendation

While significant insider selling by a director and 10% owner is generally a negative signal, the filing itself does not provide context for the sales (e.g., diversification, liquidity needs, pre-planned trading plan). Without additional information on the company's fundamentals or specific reasons for the sale, a 'hold' recommendation is prudent, advising investors to monitor future developments and company performance closely rather than immediately selling based solely on this insider transaction. It warrants caution and further investigation.

Keywords

Vor Biopharma, VOR, Insider Selling, Form 4, Reprogrammed Interchange LLC, Reid Hoffman, Stock Sale, Director Transaction, 10% Owner, Reverse Stock Split